SCHEMBL2493964

SCHEMBL2493964

CC(C)N(CC[C@@H](c1[c]ccc(CO)c1)c1ccccc1)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 5/20 0.53
CHRM1 P11229 4/20 0.53
CHRM3 P20309 7/20 0.48
HRH1 P35367 4/20 0.48
HTR2A P28223 3/20 0.48
CHRM5 P08912 2/20 0.48
SLC6A4 P31645 2/20 0.48
LMNA P02545 1/20 0.48
ESR1 P03372 1/20 0.48
CHRM4 P08173 1/20 0.48
MAPT P10636 1/20 0.48
KCNE1 P15382 1/20 0.48
PTGS1 P23219 1/20 0.48
HRH2 P25021 1/20 0.48
ADRA1A P35348 1/20 0.48
OPRK1 P41145 1/20 0.48
KCNQ1 P51787 1/20 0.48
KCNH2 Q12809 1/20 0.48
CACNA1C Q13936 1/20 0.48
SCN5A Q14524 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2478598 1.00 CHRM2 (0.53) CHRM2CHRM1CHRM3HRH1HTR2A
SCHEMBL2493966 1.00 CHRM2 (0.53) CHRM2CHRM1CHRM3HRH1HTR2A
SCHEMBL7580087 0.85 CHRM3 (0.43) CHRM2CHRM1CHRM3HRH1HTR2A
SCHEMBL7571521 0.83 CHRM3 (0.42) CHRM2CHRM1CHRM3HRH1HTR2A
SCHEMBL7571464 0.82 CHRM1 (0.52) CHRM2CHRM1CHRM3HRH1HTR2A
SCHEMBL7572293 0.82 CHRM2 (0.49) CHRM2CHRM1CHRM3HRH1HTR2A
SCHEMBL7572299 0.82 CHRM2 (0.49) CHRM2CHRM1CHRM3HRH1HTR2A
SCHEMBL7572288 0.82 CHRM2 (0.49) CHRM2CHRM1CHRM3HRH1HTR2A
SCHEMBL7573735 0.81 CHRM2 (0.41) CHRM2CHRM1CHRM3HRH1HTR2A
SCHEMBL7574861 0.81 CHRM1 (0.45) CHRM2CHRM1CHRM3HRH1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012098560-A2 PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST MSN LABORATORIES LIMITED (IN) 2012-07-26 WO claimed
EP-1230209-B3 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES UCB PHARMA GMBH (DE) 2011-10-05 EP claimed
EP-1690536-B1 Use of r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl-phenylisobutyric acid ester hydrogenfumarate for the treatment of urinary incontinence and other spasmogenic disorders SANOL ARZNEI SCHWARZ GMBH (DE) 2008-05-14 EP claimed
EP-1230209-B1 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES SANOL ARZNEI SCHWARZ GMBH (DE) 2005-01-12 EP claimed
EP-1230209-A2 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES SCHWARZ PHARMA AG (DE) 2002-08-14 EP claimed
EP-1077912-B1 NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES SANOL ARZNEI SCHWARZ GMBH (DE) 2002-07-03 EP claimed
WO-2001035957-A1 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES SANOL ARZNEI SCHWARZ GMBH (DE) 2001-05-25 WO claimed
EP-1230209-B3 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES UCB PHARMA GMBH (DE) 2011-10-05 EP disclosed
EP-1230209-A2 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES SCHWARZ PHARMA AG (DE) 2002-08-14 EP disclosed
WO-2001035957-A3 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES SANOL ARZNEI SCHWARZ GMBH (DE) 2001-12-27 WO disclosed
WO-2001035957-A8 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES SANOL ARZNEI SCHWARZ GMBH (DE) 2001-06-21 WO disclosed
WO-2001035957-A1 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES SANOL ARZNEI SCHWARZ GMBH (DE) 2001-05-25 WO disclosed